Secretary for Health meets with delegation of Hainan Province (with photos)
***************************************************************************
At the meeting, Professor Lo updated the delegation with the latest development of Hong Kong's healthcare policy, including complementing technological innovation with institutional innovation through expediting the reform of the approval mechanism for drugs and medical devices, and strengthening research and development and translation of biomedical technology put forward in "The Chief Executive's 2024 Policy Address". The HKSAR Government will support innovation and application of advanced biomedical technology, with a view to attracting the world's top-notch biomedical enterprises and research organisations to set up operations in Hong Kong.
Meanwhile, the HKSAR Government will continue to actively promote the adoption of the Standards by more public hospitals for accreditation, including extending the adoption of relevant Standards in the coming year to two to three public hospitals other than Pamela Youde Nethersole Eastern Hospital and Prince of Wales Hospital, with a view to ensuring that the management and service levels as well as healthcare quality of local hospitals are on par with international standards. The participation of public hospitals in the accreditation programme can serve as a demonstration to the international community the national hospital accreditation standards, with Hong Kong acting as a gateway to facilitate the national standards to go global. In this connection, both parties also explored ways to further encourage more hospitals in the two places to pursue accreditation under the Standards so as to amplify the impact of the Standards.
Professor Lo emphasised, "The HKSAR Government has long been reinforcing co-operation on healthcare service developments with various Mainland provinces and cities under the principle of complementarity and mutual benefits, and on the premise of benefitting the healthcare development of both the Mainland and Hong Kong to level up the healthcare quality. Looking ahead, we will remain committed to fostering cross-boundary medical co-operation so as to propel the important national strategy of 'Healthy China' through concerted contributions."
Ends/Thursday, October 17, 2024
Issued at HKT 19:55
Issued at HKT 19:55
NNNN